SEC Filing Details
PTC Therapeutics, Inc. is committed to serving the interests of all our stakeholders.
Living with
Duchenne Muscular Dystrophy,
Ukraine
SEC Filing Details
Document Details
Form
Filing Date
Oct 26, 2023
Document Date
Sep 30, 2023
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
PTC Therapeutics, Inc.
Issuer
PTC THERAPEUTICS, INC.